Delivery Order SPE2DB22D2206-SPE2DB24FFE39
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,886.47 firm fixed-price delivery order is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,066.74 firm-fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a medical product. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $10,851.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 20,000 units of the medical product RECOTHROM, with a performance period ending on May 6, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,139.43 Firm Fixed Price contract is for the delivery of 20,000 unit vials of the specialty medication RECOTHROM. This award is a Delivery Order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,714.81 delivery order is for RECOTHROM 20,000 unit vials and has a firm fixed price. The award has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,513.82 fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a specialty medication. The contract has a period of performance through December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,544.48, for the supply of RECOTHROM 20,000 UN 1S medical products. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This award...
- This federal contract award is a Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of RECOTHROM, a medical product, with a ceiling value of $1,136.94 and a completion date of June 5, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the drug RECOTHROM, a medical product, with a ceiling value of $15,010.06. The contract is a Firm Fixed Price Delivery Order, with a period of performance through July 10, 2025. This contract award is not set aside and represents open competition. Amerisourcebergen...
- This federal contract award, valued at $3,322.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the medication RECOTHROM, with a performance period through April 29, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFE39Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,956.72 firm fixed-price delivery order is for the procurement of 20,000 unit vials of RECOTHROM, a medical product. The contract has an ultimate completion date of January 22, 2024 and was awarded on January 21, 2024. There was no set-aside used for this open competition award. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.0k | 1/21/24 |